ut-logo website  
 
Log in
Express registration and login!
If you have a Facebook or LinkedIN account, use one of the buttons on the left to either login or create a new account.

Log in

 

Bladder Cancer Highlights

EAU 2011 - Long term results of the International phase III trial BA06 (MRC) 30894 (EORTC) assessing neo-adjuvant CMV chemotherapy for muscle-invasive bladder cancer - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Neoadjuvant and adjuvant chemotherapy is increasingly discussed in the context of radical cystectomy for urothelial cancer.

Read more...

EAU 2011 - A prospective randomized trial of hexylaminolevulinate (Hexvix) assisted transurethral resection (TURBT) plus single shot intravesical mitomycin (MMC) versus conventional white light TURBT plus single shot MMC in newly presenting bladder cancer

VIENNA, AUSTRIA (UroToday.com) - The debate about photodynamic diagnosis as well early single shot chemotherapy following TUR as is ongoing.

Read more...

EAU 2011 - Association between the extent of pelvic lymphadenectomy and cancer-specific survival in patients with lymph node negative urothelial carcinoma of the bladder undergoing radical cystectomy - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Number of removed lymph nodes and lymphovascular invasion are known predictive parameters of outcome following radical cystectomy for urothelial cancer.

Read more...

EAU 2011 - Risk assessment of patients who present with asymptomatic hematuria: Development and validation of a nomogram for prediction of bladder cancer presence - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Work-up of hematuria should be standardized because a relevant number of patients will have bladder cancer.

Read more...

EAU 2011 - A systematic review and meta-analysis of the volume-outcome relationship for the radical cystectomy: An update for the ongoing debate - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Surgical volume remains a parameter of debate – not only from the medical point of view.

Read more...